Palo Alto, California-based Medable Inc, a provider of software for managing clinical trials, has secured $91 million in Series C funding. Sapphire Ventures led the round with participation from GSR Ventures, PPD, Inc and Streamlined Ventures.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: